The Food and Drug Administration recently limited certain monoclonal antibody drugs used to treat COVID patients, because they don't seem to be effective against the omicron variant.
Some consumer groups are calling on the federal government to take a closer look at what they are calling alarming levels of lead and arsenic in some vinegar products.
Dr. Paul Offit, who serves on the Food and Drug Administration's vaccine advisory board, says he doesn't think an effective vaccine that's undergone adequate testing can be ready this year.